Active ingredient
Valbenazine
6 finished FDA listings contain Valbenazine as their only active ingredient.
At a glance
From the FDA NDC Directory
- Ingredient names as written by FDA
- VALBENAZINE, VALBENAZINE DITOSYLATE, VALBENAZINE TOSYLATE
- Dosage forms
- Capsule
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 40 mg/1 · 60 mg/1 · 80 mg/1
- Brand names in FDA listings
- Ingrezza, Ingrezza Sprinkle
Official drug information
Source coverage for Valbenazine:
- FDA NDC Directory: linked
- RxNorm: linked
- Drugs@FDA: linked
- DailyMed: linked
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1918219
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
- Application
- NDA 209241
- Sponsor
- NEUROCRINE
- Original approval
- 2017-04-11
- Listings
- 3
- Application
- NDA 218390
- Sponsor
- NEUROCRINE
- Original approval
- 2024-04-30
- Listings
- 3
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 209241 | NEUROCRINE | 2017-04-11 | 3 |
| NDA 218390 | NEUROCRINE | 2024-04-30 | 3 |
Official labeling on DailyMed
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.